Your session is about to expire
← Back to Search
Dietary Supplement
Olive oil and Dietary Guideline recommendations for Trigeminal Neuralgia
N/A
Waitlist Available
Led By Wendy J Dahl, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if adding olive oil to the diet can help reduce facial pain in people with trigeminal neuralgia type 1. These patients often don't get relief from current treatments. Olive oil might help repair nerve damage, potentially reducing pain.
Eligible Conditions
- Trigeminal Neuralgia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Compliance to olive oil intervention
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Olive OilExperimental Treatment1 Intervention
Incorporating 60 mL of olive oil into usual diet and Dietary Guidelines recommendations
Group II: ControlActive Control1 Intervention
Dietary Guidelines recommendations
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Olive oil and Dietary Guideline recommendations
2021
N/A
~60
Find a Location
Who is running the clinical trial?
University of FloridaLead Sponsor
1,397 Previous Clinical Trials
766,975 Total Patients Enrolled
1 Trials studying Trigeminal Neuralgia
61 Patients Enrolled for Trigeminal Neuralgia
Wendy J Dahl, PhDPrincipal InvestigatorUniversity of Florida
9 Previous Clinical Trials
724 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger